A systematic review of real-world clinical practice data in COVID-19: non-interventional studies
Introduction. As defined by the Food and Drug Administration, real-world data (RWD) is data related to a patient's health and/or health care delivery, usually collected from various sources as part of real-world clinical practice research.Objective: to describe the feasible and the most sought-...
Saved in:
| Main Authors: | S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-04-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/664 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancing human-use experience for real-world evidence for the registration of traditional Chinese medicine products in China
by: Mingge Xia, et al.
Published: (2025-05-01) -
Educational pharmacoepidemiology and "Real-World Knowledge"
by: R. A. Bontsevich
Published: (2025-01-01) -
Efficacy and Safety of Early Use of Naoxueshu Within 72 hours in the Treatment of Spontaneous Intracerebral Hemorrhage: A Real-World Retrospective Cohort Study
by: Wang X, et al.
Published: (2025-04-01) -
Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study
by: Wentai Pang, et al.
Published: (2020-09-01) -
Acupuncture as adjuvant therapy in hospitalized patients with COVID-19: A single-blinded randomized controlled trial
by: Amir Hooman Kazemi, et al.
Published: (2025-01-01)